Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 45 | 2023 | 8601 | 2.580 |
Why?
|
Copper | 22 | 2023 | 365 | 2.090 |
Why?
|
Amyloid beta-Protein Precursor | 18 | 2020 | 1111 | 1.290 |
Why?
|
Amyloid beta-Peptides | 22 | 2020 | 3840 | 1.130 |
Why?
|
Molecular Imaging | 3 | 2020 | 819 | 0.900 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2013 | 3776 | 0.860 |
Why?
|
Metals | 7 | 2010 | 712 | 0.830 |
Why?
|
Gene Order | 2 | 2013 | 168 | 0.800 |
Why?
|
beta-Endorphin | 1 | 2020 | 43 | 0.740 |
Why?
|
Drug Discovery | 2 | 2018 | 1049 | 0.700 |
Why?
|
Protein Biosynthesis | 10 | 2020 | 2091 | 0.690 |
Why?
|
Cathepsin D | 1 | 2020 | 59 | 0.690 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2020 | 309 | 0.690 |
Why?
|
Amyloidosis | 3 | 2020 | 864 | 0.680 |
Why?
|
Hallucinogens | 1 | 2023 | 197 | 0.680 |
Why?
|
Tauopathies | 1 | 2023 | 319 | 0.660 |
Why?
|
Osteonectin | 1 | 2019 | 33 | 0.650 |
Why?
|
Neuroprotective Agents | 3 | 2018 | 956 | 0.630 |
Why?
|
Medicine, Chinese Traditional | 1 | 2018 | 73 | 0.590 |
Why?
|
Behavior | 1 | 2020 | 540 | 0.590 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2020 | 619 | 0.580 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2020 | 1331 | 0.540 |
Why?
|
Protein Multimerization | 2 | 2020 | 974 | 0.540 |
Why?
|
Drugs, Chinese Herbal | 1 | 2018 | 143 | 0.540 |
Why?
|
Algorithms | 11 | 2013 | 14023 | 0.520 |
Why?
|
Chelating Agents | 10 | 2010 | 383 | 0.520 |
Why?
|
Apoptosis | 2 | 2023 | 9478 | 0.500 |
Why?
|
Zinc | 12 | 2004 | 672 | 0.500 |
Why?
|
Fluorescent Dyes | 2 | 2020 | 1902 | 0.490 |
Why?
|
Iron | 13 | 2023 | 1790 | 0.480 |
Why?
|
Extracellular Matrix Proteins | 1 | 2019 | 829 | 0.470 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1066 | 0.450 |
Why?
|
Protein Kinases | 1 | 2020 | 1607 | 0.430 |
Why?
|
Stress, Physiological | 1 | 2020 | 1406 | 0.430 |
Why?
|
Social Stigma | 1 | 2020 | 770 | 0.430 |
Why?
|
Behavior, Animal | 1 | 2020 | 1873 | 0.410 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2138 | 0.410 |
Why?
|
5' Untranslated Regions | 8 | 2018 | 251 | 0.400 |
Why?
|
Bursitis | 1 | 2012 | 80 | 0.390 |
Why?
|
Cell Line, Tumor | 10 | 2020 | 16947 | 0.380 |
Why?
|
Memantine | 1 | 2012 | 108 | 0.380 |
Why?
|
Dementia, Vascular | 1 | 2012 | 122 | 0.380 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1744 | 0.370 |
Why?
|
Hydrogen Peroxide | 7 | 2004 | 731 | 0.360 |
Why?
|
Gene Expression | 3 | 2020 | 7567 | 0.360 |
Why?
|
Cost of Illness | 1 | 2020 | 1937 | 0.340 |
Why?
|
Energy Metabolism | 1 | 2020 | 2877 | 0.330 |
Why?
|
Pattern Recognition, Automated | 4 | 2012 | 993 | 0.330 |
Why?
|
Principal Component Analysis | 2 | 2011 | 942 | 0.320 |
Why?
|
Nanoparticles | 2 | 2020 | 1959 | 0.310 |
Why?
|
Oxidative Stress | 8 | 2023 | 3114 | 0.310 |
Why?
|
Computational Biology | 3 | 2010 | 3499 | 0.280 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 894 | 0.280 |
Why?
|
Brain Injuries | 1 | 2019 | 2054 | 0.280 |
Why?
|
Amyloid Neuropathies | 1 | 2006 | 15 | 0.270 |
Why?
|
Cobalt | 1 | 2006 | 148 | 0.260 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2008 | 161 | 0.260 |
Why?
|
Cushing Syndrome | 1 | 2008 | 241 | 0.260 |
Why?
|
Protein Structure, Secondary | 2 | 2008 | 1222 | 0.250 |
Why?
|
Brain | 14 | 2020 | 27097 | 0.240 |
Why?
|
Cluster Analysis | 5 | 2013 | 2706 | 0.230 |
Why?
|
Artificial Intelligence | 6 | 2011 | 2577 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2012 | 9416 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5662 | 0.220 |
Why?
|
Trace Elements | 3 | 2020 | 193 | 0.220 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2023 | 47 | 0.220 |
Why?
|
Peptide Fragments | 10 | 2006 | 5103 | 0.210 |
Why?
|
Genetic Diseases, Inborn | 1 | 2008 | 604 | 0.210 |
Why?
|
DNA Methylation | 3 | 2018 | 4386 | 0.210 |
Why?
|
Inflammation | 3 | 2023 | 10758 | 0.200 |
Why?
|
Iron Regulatory Protein 1 | 2 | 2013 | 37 | 0.200 |
Why?
|
Polymers | 2 | 2006 | 1617 | 0.200 |
Why?
|
Phthalic Acids | 1 | 2006 | 478 | 0.190 |
Why?
|
Parkinson Disease | 3 | 2012 | 2869 | 0.190 |
Why?
|
Humans | 65 | 2023 | 761098 | 0.190 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3779 | 0.180 |
Why?
|
alpha-Synuclein | 4 | 2013 | 742 | 0.180 |
Why?
|
Animals | 37 | 2023 | 168083 | 0.170 |
Why?
|
Cathepsin B | 1 | 2020 | 80 | 0.170 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 464 | 0.170 |
Why?
|
Apoferritins | 1 | 2018 | 16 | 0.160 |
Why?
|
Manganese Poisoning | 1 | 2018 | 13 | 0.160 |
Why?
|
Environmental Exposure | 3 | 2020 | 4479 | 0.160 |
Why?
|
Serotonin | 1 | 2023 | 1043 | 0.150 |
Why?
|
Genomics | 2 | 2020 | 5828 | 0.150 |
Why?
|
Flavanones | 1 | 2018 | 74 | 0.150 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9518 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2020 | 449 | 0.150 |
Why?
|
Inflammasomes | 1 | 2023 | 525 | 0.150 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2020 | 459 | 0.150 |
Why?
|
Metals, Heavy | 1 | 1999 | 148 | 0.150 |
Why?
|
Neoplasms | 3 | 2020 | 22125 | 0.150 |
Why?
|
Nootropic Agents | 1 | 2018 | 157 | 0.140 |
Why?
|
Oxidation-Reduction | 9 | 2004 | 2227 | 0.140 |
Why?
|
Protein Binding | 8 | 2020 | 9300 | 0.130 |
Why?
|
S-Adenosylmethionine | 1 | 2018 | 218 | 0.130 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 301 | 0.130 |
Why?
|
Staining and Labeling | 1 | 2020 | 1081 | 0.130 |
Why?
|
Neurodegenerative Diseases | 2 | 2018 | 1085 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1187 | 0.120 |
Why?
|
Models, Genetic | 3 | 2011 | 3430 | 0.120 |
Why?
|
Amino Acid Sequence | 4 | 2020 | 13404 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36418 | 0.110 |
Why?
|
Myelin Sheath | 1 | 2018 | 653 | 0.110 |
Why?
|
Computer Simulation | 3 | 2020 | 6225 | 0.110 |
Why?
|
Mice | 17 | 2023 | 81324 | 0.110 |
Why?
|
Drugs, Investigational | 2 | 2006 | 212 | 0.110 |
Why?
|
Rats | 8 | 2020 | 23713 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2114 | 0.110 |
Why?
|
Metalloproteins | 2 | 2004 | 97 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2018 | 821 | 0.110 |
Why?
|
Ferric Compounds | 2 | 2009 | 378 | 0.110 |
Why?
|
Joint Capsule | 1 | 2012 | 68 | 0.100 |
Why?
|
Databases, Genetic | 2 | 2009 | 1741 | 0.100 |
Why?
|
Ligands | 1 | 2018 | 3266 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2008 | 7844 | 0.090 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.090 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.090 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.090 |
Why?
|
RNA, Messenger | 7 | 2013 | 12743 | 0.090 |
Why?
|
Synovitis | 1 | 2012 | 217 | 0.090 |
Why?
|
Pilot Projects | 4 | 2020 | 8639 | 0.090 |
Why?
|
Vanadium | 1 | 2010 | 54 | 0.090 |
Why?
|
Ligaments, Articular | 1 | 2012 | 302 | 0.090 |
Why?
|
Aluminum | 1 | 2010 | 152 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2327 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2020 | 5870 | 0.080 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 509 | 0.080 |
Why?
|
Rotator Cuff | 1 | 2012 | 348 | 0.080 |
Why?
|
Erythromycin | 2 | 2006 | 114 | 0.080 |
Why?
|
Ferritins | 2 | 2008 | 597 | 0.080 |
Why?
|
Magnesium | 2 | 2010 | 804 | 0.080 |
Why?
|
Clioquinol | 3 | 2006 | 23 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2010 | 896 | 0.080 |
Why?
|
Paroxetine | 2 | 2006 | 181 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15915 | 0.080 |
Why?
|
Least-Squares Analysis | 1 | 2008 | 368 | 0.070 |
Why?
|
Acetylcysteine | 2 | 2006 | 260 | 0.070 |
Why?
|
Manganese | 1 | 2010 | 391 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 502 | 0.070 |
Why?
|
Iron Chelating Agents | 2 | 2006 | 141 | 0.070 |
Why?
|
Software Design | 1 | 2007 | 171 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2855 | 0.070 |
Why?
|
Models, Chemical | 2 | 2006 | 609 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2018 | 5777 | 0.070 |
Why?
|
Response Elements | 2 | 2013 | 307 | 0.070 |
Why?
|
Collagen Type I | 1 | 2010 | 616 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2010 | 506 | 0.070 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 283 | 0.070 |
Why?
|
Hair | 1 | 2010 | 498 | 0.070 |
Why?
|
Quality Control | 1 | 2009 | 834 | 0.070 |
Why?
|
Intracellular Fluid | 1 | 2006 | 201 | 0.070 |
Why?
|
Neurons | 8 | 2013 | 9435 | 0.070 |
Why?
|
Untranslated Regions | 1 | 2006 | 29 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14676 | 0.070 |
Why?
|
Iron-Regulatory Proteins | 1 | 2006 | 30 | 0.070 |
Why?
|
Second Messenger Systems | 1 | 2006 | 201 | 0.070 |
Why?
|
Ovarian Neoplasms | 2 | 2013 | 4853 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11066 | 0.060 |
Why?
|
Shoulder Joint | 1 | 2012 | 742 | 0.060 |
Why?
|
Porosity | 1 | 2006 | 348 | 0.060 |
Why?
|
Drug Design | 1 | 2010 | 1045 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2013 | 17598 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2012 | 1395 | 0.060 |
Why?
|
Aged | 9 | 2019 | 169266 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2013 | 22157 | 0.060 |
Why?
|
Tyrosine | 3 | 2004 | 1422 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11856 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2219 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1900 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8130 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18217 | 0.050 |
Why?
|
Lens, Crystalline | 2 | 2003 | 387 | 0.050 |
Why?
|
Dementia | 1 | 2018 | 2682 | 0.050 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2001 | 161 | 0.050 |
Why?
|
Female | 12 | 2020 | 392458 | 0.050 |
Why?
|
Signal Transduction | 3 | 2018 | 23415 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7386 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1540 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58946 | 0.050 |
Why?
|
Cells, Cultured | 8 | 2013 | 18926 | 0.050 |
Why?
|
Cell Survival | 5 | 2018 | 5776 | 0.050 |
Why?
|
Aqueous Humor | 1 | 2003 | 153 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2023 | 179 | 0.050 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 1982 | 0.050 |
Why?
|
China | 1 | 2008 | 2374 | 0.050 |
Why?
|
Superoxides | 2 | 2000 | 388 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 220835 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2004 | 959 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2802 | 0.050 |
Why?
|
3-Hydroxyanthranilic Acid | 1 | 2000 | 8 | 0.050 |
Why?
|
Antioxidants | 2 | 2010 | 1667 | 0.050 |
Why?
|
Drug Approval | 2 | 2005 | 812 | 0.040 |
Why?
|
Crystallins | 1 | 2000 | 75 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4565 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 1987 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2637 | 0.040 |
Why?
|
Neurotoxins | 1 | 2001 | 240 | 0.040 |
Why?
|
Neuroblastoma | 2 | 2006 | 1246 | 0.040 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1999 | 45 | 0.040 |
Why?
|
Kynurenine | 1 | 2000 | 141 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2010 | 1462 | 0.040 |
Why?
|
Prions | 1 | 2001 | 177 | 0.040 |
Why?
|
Ferrous Compounds | 1 | 1999 | 41 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1682 | 0.040 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.040 |
Why?
|
Amyloid | 1 | 2004 | 848 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2007 | 2881 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5033 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6818 | 0.040 |
Why?
|
Homocysteine | 1 | 2001 | 637 | 0.040 |
Why?
|
Age Factors | 2 | 2013 | 18385 | 0.040 |
Why?
|
Chromatography, Gel | 1 | 1997 | 642 | 0.030 |
Why?
|
Image Enhancement | 1 | 2007 | 2888 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1999 | 1429 | 0.030 |
Why?
|
Adult | 4 | 2019 | 221083 | 0.030 |
Why?
|
Apolipoproteins E | 2 | 1999 | 1443 | 0.030 |
Why?
|
Acidosis | 1 | 1998 | 268 | 0.030 |
Why?
|
Calcium | 2 | 2006 | 5720 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 7969 | 0.030 |
Why?
|
Dopamine | 1 | 2002 | 1606 | 0.030 |
Why?
|
Synapses | 1 | 2004 | 1755 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1070 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2406 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5077 | 0.030 |
Why?
|
Male | 6 | 2019 | 360675 | 0.030 |
Why?
|
Homeostasis | 2 | 2008 | 3318 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1086 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2004 | 1535 | 0.030 |
Why?
|
Deferoxamine | 2 | 2006 | 155 | 0.030 |
Why?
|
Physostigmine | 1 | 2013 | 50 | 0.030 |
Why?
|
Base Sequence | 3 | 2013 | 12404 | 0.030 |
Why?
|
Cholesterol | 1 | 2002 | 2902 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13254 | 0.030 |
Why?
|
Plaque, Amyloid | 2 | 2010 | 761 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1053 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7405 | 0.020 |
Why?
|
Oxygen | 2 | 2000 | 4226 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5145 | 0.020 |
Why?
|
Feces | 1 | 2018 | 1490 | 0.020 |
Why?
|
Molecular Probe Techniques | 1 | 2012 | 111 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2478 | 0.020 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.020 |
Why?
|
Cross-Linking Reagents | 2 | 2004 | 684 | 0.020 |
Why?
|
Chelation Therapy | 1 | 2010 | 77 | 0.020 |
Why?
|
Histidine | 2 | 2001 | 303 | 0.020 |
Why?
|
Protein Conformation | 1 | 1997 | 3936 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 386 | 0.020 |
Why?
|
Catalysis | 2 | 2002 | 763 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26068 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 427 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11732 | 0.020 |
Why?
|
Models, Molecular | 2 | 2012 | 5413 | 0.020 |
Why?
|
Free Radicals | 2 | 1999 | 238 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2009 | 141 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2001 | 1761 | 0.020 |
Why?
|
Levodopa | 1 | 2009 | 222 | 0.020 |
Why?
|
Cell Line | 2 | 2018 | 15542 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5754 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17889 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2013 | 1073 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2009 | 370 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8164 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 656 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2006 | 10755 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1967 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2007 | 9025 | 0.020 |
Why?
|
Normal Distribution | 1 | 2007 | 272 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2007 | 383 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2006 | 189 | 0.020 |
Why?
|
Transfection | 2 | 2006 | 5750 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2006 | 286 | 0.020 |
Why?
|
Cataract | 2 | 2003 | 832 | 0.020 |
Why?
|
Time Factors | 2 | 2004 | 39953 | 0.020 |
Why?
|
Down Syndrome | 1 | 2013 | 901 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6123 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22129 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2010 | 1169 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3790 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 59199 | 0.010 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2004 | 124 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1892 | 0.010 |
Why?
|
ROC Curve | 1 | 2011 | 3582 | 0.010 |
Why?
|
Feedback | 1 | 2007 | 790 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2010 | 2328 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3604 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2623 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2004 | 812 | 0.010 |
Why?
|
Kinetics | 2 | 2001 | 6312 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 265 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 88271 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20981 | 0.010 |
Why?
|
Dimerization | 1 | 2004 | 888 | 0.010 |
Why?
|
Binding Sites | 2 | 2001 | 5993 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1202 | 0.010 |
Why?
|
Resins, Synthetic | 1 | 2001 | 25 | 0.010 |
Why?
|
Cation Exchange Resins | 1 | 2001 | 19 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 684 | 0.010 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2001 | 91 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2208 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3591 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 597 | 0.010 |
Why?
|
Synaptophysin | 1 | 2001 | 139 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 2001 | 182 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2001 | 334 | 0.010 |
Why?
|
Risk Factors | 2 | 2006 | 74219 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2006 | 1126 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 711 | 0.010 |
Why?
|
Guanosine | 1 | 2000 | 43 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1644 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 6987 | 0.010 |
Why?
|
Electrochemistry | 1 | 2000 | 145 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 336 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1999 | 49 | 0.010 |
Why?
|
Ethylenediamines | 1 | 1999 | 56 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1999 | 166 | 0.010 |
Why?
|
Ions | 1 | 2000 | 255 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2001 | 550 | 0.010 |
Why?
|
Chemical Precipitation | 1 | 1999 | 175 | 0.010 |
Why?
|
Centrifugation | 1 | 1999 | 122 | 0.010 |
Why?
|
RNA | 1 | 2009 | 2708 | 0.010 |
Why?
|
Methionine | 1 | 2001 | 570 | 0.010 |
Why?
|
Apolipoprotein E3 | 1 | 1999 | 107 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 1250 | 0.010 |
Why?
|
Apolipoprotein E2 | 1 | 1999 | 135 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1520 | 0.010 |
Why?
|
Filtration | 1 | 1999 | 228 | 0.010 |
Why?
|
Iohexol | 1 | 1999 | 205 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3319 | 0.010 |
Why?
|
Tryptophan | 1 | 2000 | 480 | 0.010 |
Why?
|
tau Proteins | 1 | 2008 | 2094 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1681 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1085 | 0.010 |
Why?
|
Serum Albumin | 1 | 2000 | 674 | 0.010 |
Why?
|
Glutamine | 1 | 2000 | 574 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2000 | 654 | 0.010 |
Why?
|
Drug Synergism | 1 | 2001 | 1756 | 0.010 |
Why?
|
Arginine | 1 | 2000 | 921 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 4922 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2002 | 1360 | 0.010 |
Why?
|
Proteomics | 1 | 2009 | 3836 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3832 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6585 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 1999 | 709 | 0.010 |
Why?
|
Cattle | 1 | 2000 | 3819 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2000 | 1173 | 0.010 |
Why?
|
Protein Isoforms | 1 | 1999 | 1696 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2001 | 2189 | 0.010 |
Why?
|
Amino Acids | 1 | 2000 | 1703 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1501 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8529 | 0.010 |
Why?
|
Water | 1 | 1999 | 1410 | 0.010 |
Why?
|
Glioma | 1 | 2007 | 3452 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3803 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4353 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6343 | 0.010 |
Why?
|
Glioblastoma | 1 | 2006 | 3481 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9455 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2001 | 14393 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13382 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2009 | 64670 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8701 | 0.000 |
Why?
|
United States | 1 | 2002 | 72337 | 0.000 |
Why?
|